UT
Utah Medical Products, Inc.
UTMD · NASDAQ
$69.16 -1.90% (-$1.34)
1M -3.04%
Market Cap $220.2M
P/E Ratio 21.00x
Div. Yield 1.79%
ROE 8.74%
Bulios Fair Price
$71.78
3.8% upside
Current Price
$69.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, UTMD is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
57 /100
Fair P/E 21.00x
P/B 1.80x
EV/EBITDA 15.03x
Growth
3 /100
Declining EPS growth 8.35%
Book val. growth 1.44%
Rev. growth 9.68%
Profitability
100 /100
Strong Gross margin 54.88%
FCF margin 31.70%
Net margin 29.04%
Quality
41 /100
Average ROIC 6.83%
Asset turnover 0.29x
ROE 8.74%
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA 0.01x
Current ratio 48.62x
Stability
85 /100
Stable Beta 0.36x
Profitable years 6
Rev. volatility 7.95%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about UTMD
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Kevin L. Cornwell
Employees
146
Headquarters
Midvale
Upcoming events
17 SEP
Ex-Dividend
Ex-dividend date
05 OCT
Dividend Payment
Payment date
22 OCT
Earnings
Upcoming earnings report